Search
- Sep 8
Myeloid Therapeutics to Participate in September Investor Conferences
CAMBRIDGE, Mass, September 8, 2022 - Myeloid Therapeutics, Inc. (“Myeloid”), a clinical stage mRNA-immunotherapy company harnessing the...
74 views
- Aug 23
Myeloid Therapeutics Strengthens Senior Team to Support the Expansion of its Manufacturing...
Myeloid Therapeutics Strengthens Senior Team to Support the Expansion of its Manufacturing Capabilities CAMBRIDGE, Mass, August 23, 2022 ...
130 views
- Jun 30
Myeloid Therapeutics Strengthens its Board of Directors with Two Appointments
Myeloid Therapeutics Strengthens its Board of Directors with Appointments of Stanley Frankel, M.D., FACP and Brett Kaplan, M.D.
281 views
- May 24
Myeloid Therapeutics to Participate at Investor Conferences in June 2022
Myeloid Therapeutics to Participate at Investor Conferences in June 2022
154 views